Laura Evgin

Scientist at Canada's Michael Smith Genome Sciences Centre at BC Cancer
Assistant Professor, Department of Medical Genetics, University of British Columbia

[Laura Evgin @EvginLab]

We have a new lab website! Check out what our team is doing in the lab. https://t.co/5HF3l54Sde

[Laura Evgin @EvginLab]

We are looking for a postdoctoral fellow to join our lab at @BCCancer_GSC. Apply here:https://t.co/HIDwURUVYx. Read more about our work on our new lab website! https://t.co/5HF3l54Sde

[Laura Evgin @EvginLab]

We are very happy to share our review about engineering CAR T cells directly in vivo.
https://t.co/mtIRXdNLDM

[Laura Evgin @EvginLab]

My fantastic team made a podcast about immunotherapy. Check it out! Episode 2 features a great interview with @Smience about CAR T cell therapy in Canada. https://t.co/vakx85gV1c

[Science in Vancouver @ScienceVancity]

🎉 @tfri_research has announced the Canadian @cancersociety’s inaugural Research Training Awards.

We extend a hearty congratulations to Gillian Savage from @BCCancer!

Find out more about her project: https://t.co/5CRo6tGdfw

[Laura Evgin @EvginLab]

@KevinBennewith @UBC @BCCancer Congrats Kevin!

[Science Immunology @SciImmunology]

Prior gammaherpesvirus infection can limit allergic airway inflammation by reprogramming lung group 2 innate lymphoid cells (ILC2s), finds new work in mouse models. @UniversiteLiege

📄: https://t.co/zOlFMju2qr

[Laura Evgin @EvginLab]

@KAyasoufi Congratulations!

[Laura Evgin @EvginLab]

@maria_tokuyama @HlthResearchBC Congratulations Maria!! 🥳

[Laura Evgin @EvginLab]

I am looking for a research associate. Come join our team @BCCancer_GSC in beautiful Vancouver to work on CAR T cell therapy! See more here: https://t.co/lhcrXK6C0W

[Almohanad Alkayyal, PhD @aalkayyal1]

@EvginLab, @Tai_ImmunoLab, @Ahmad_B_Mahmoud and I have been invited to guest edit a special issue on “Strategies in Oncolytic Virotherapy” in @FrontImmunol Journal with a 7.561 impact factor
Please consider submitting your manuscript here:
https://t.co/0m4MP4gdYC

[Laura Evgin @EvginLab]

Happy to share our new paper out yesterday in @ScienceTM from my post doc lab @RVilePhD! The native TCR in CAR T cells is important and can be leveraged with OV-derived antigens. https://t.co/rjpW7JgeM3

[Canada’s Michael Smith Genome Sciences Centre @GSCofBC]

Interested in original #science, helping #CancerPatients, furthering #CancerResearch, #LifeScience, realizing #PrecisionMedicine?
We're hiring! Apply now: https://t.co/keqifWS2Fj
🧬Staff Scientist
🧬Postdoctoral Fellows
🧬#Bioinformatics Research Associate
🧬& more #ScienceJobs

[Laura Evgin @EvginLab]

I’m looking for a post doc to work on a project using viruses and vaccines to improve CAR T efficacy in lymphoma. Come work for me @BCCancer_GSC in beautiful Vancouver! https://t.co/uDBvKzbwHV

[Laura Evgin @EvginLab]

@lum_lab @ScienceVancity Thanks @lum_lab!

[Laura Evgin @EvginLab]

Looking forward to it @Tai_ImmunoLab!

[Lee-Hwa Tai, PhD @Tai_ImmunoLab]

Beautiful drawing of Lauralie Short, MSc student in my lab @cellimmunoUdeS @USherbrooke. I'm thrilled that she will start her PhD studies with @EvginLab this fall where she will combine her oncolytic virus expertise with CAR-T cells.

[Laura Evgin @EvginLab]

Very happy to share our new review about combining CAR T and OVs! @RVilePhD @BCCancer_GSC https://t.co/lydhRrWw56

[Lorenzo Lindo @LindoSci]

Delighted to announce that my first ever review has been published in @FrontImmunol! We review how the TME can restrict CAR T-cells and discuss the novel strategies aiming to overcome the TME and reduce toxicity https://t.co/xtWkLRcZXO @ScienceVancity @UBCmedicine @BCCancer

[BioCanRx - Canada's Immunotherapy Network @BioCanRx]

Register now for our upcoming #Summit4CISpeakerSeries, featuring Dr. Carolina Ilkow @CIlkow of the @OttawaHospital & @uOttawa discussing her work on developing an exosome-based cancer vaccine platform! Details: https://t.co/XvmPJG3PkO #Immunotherapy #CancerResearch

[Laura Evgin @EvginLab]

Thanks for the shoutout @BioCanRx! https://t.co/U4o9Abok7L